Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls.
MAIT
MR1
household contacts
tetramer
tuberculosis
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
17 08 2020
17 08 2020
Historique:
received:
20
11
2019
accepted:
06
04
2020
pubmed:
9
4
2020
medline:
9
3
2021
entrez:
9
4
2020
Statut:
ppublish
Résumé
In human blood, mucosal-associated invariant T (MAIT) cells are abundant T cells that recognize antigens presented on non-polymorphic major histocompatibility complex-related 1 (MR1) molecules. The MAIT cells are activated by mycobacteria, and prior human studies indicate that blood frequencies of MAIT cells, defined by cell surface markers, decline during tuberculosis (TB) disease, consistent with redistribution to the lungs. We tested whether frequencies of blood MAIT cells were altered in patients with TB disease relative to healthy Mycobacterium tuberculosis-exposed controls from Peru and South Africa. We quantified their frequencies using MR1 tetramers loaded with 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil. Unlike findings from prior studies, frequencies of blood MAIT cells were similar among patients with TB disease and latent and uninfected controls. In both cohorts, frequencies of MAIT cells defined by MR1-tetramer staining and coexpression of CD161 and the T-cell receptor alpha variable gene TRAV1-2 were strongly correlated. Disease severity captured by body mass index or TB disease transcriptional signatures did not correlate with MAIT cell frequencies in patients with TB. Major histocompatibility complex (MHC)-related 1-restrictied MAIT cells are detected at similar levels with tetramers or surface markers. Unlike MHC-restricted T cells, blood frequencies of MAIT cells are poor correlates of TB disease but may play a role in pathophysiology.
Sections du résumé
BACKGROUND
In human blood, mucosal-associated invariant T (MAIT) cells are abundant T cells that recognize antigens presented on non-polymorphic major histocompatibility complex-related 1 (MR1) molecules. The MAIT cells are activated by mycobacteria, and prior human studies indicate that blood frequencies of MAIT cells, defined by cell surface markers, decline during tuberculosis (TB) disease, consistent with redistribution to the lungs.
METHODS
We tested whether frequencies of blood MAIT cells were altered in patients with TB disease relative to healthy Mycobacterium tuberculosis-exposed controls from Peru and South Africa. We quantified their frequencies using MR1 tetramers loaded with 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil.
RESULTS
Unlike findings from prior studies, frequencies of blood MAIT cells were similar among patients with TB disease and latent and uninfected controls. In both cohorts, frequencies of MAIT cells defined by MR1-tetramer staining and coexpression of CD161 and the T-cell receptor alpha variable gene TRAV1-2 were strongly correlated. Disease severity captured by body mass index or TB disease transcriptional signatures did not correlate with MAIT cell frequencies in patients with TB.
CONCLUSIONS
Major histocompatibility complex (MHC)-related 1-restrictied MAIT cells are detected at similar levels with tetramers or surface markers. Unlike MHC-restricted T cells, blood frequencies of MAIT cells are poor correlates of TB disease but may play a role in pathophysiology.
Identifiants
pubmed: 32267943
pii: 5817894
doi: 10.1093/infdis/jiaa173
pmc: PMC7430171
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
995-1007Subventions
Organisme : FIC NIH HHS
ID : D43 TW010559
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI049313
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111224
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Infect Immun. 2018 Nov 20;86(12):
pubmed: 30201702
Immunol Cell Biol. 2018 Jul;96(6):607-617
pubmed: 29451704
Immunity. 2016 Jan 19;44(1):32-45
pubmed: 26795251
Immunol Cell Biol. 2018 May;96(5):507-525
pubmed: 29437263
Tuberculosis (Edinb). 2017 Dec;107:48-58
pubmed: 29050771
Sci Immunol. 2018 Jul 13;3(25):
pubmed: 30006464
Front Immunol. 2019 Feb 14;10:206
pubmed: 30853958
Nat Commun. 2016 Aug 16;7:12506
pubmed: 27527800
Clin Microbiol Rev. 2014 Jan;27(1):3-20
pubmed: 24396134
Annu Rev Public Health. 2013;34:271-86
pubmed: 23244049
Lancet. 2016 Jun 4;387(10035):2312-2322
pubmed: 27017310
Nat Commun. 2019 Feb 8;10(1):687
pubmed: 30737409
PLoS One. 2011 Mar 29;6(3):e17984
pubmed: 21479236
Front Microbiol. 2019 Jun 26;10:1441
pubmed: 31297103
Tuberculosis (Edinb). 2019 May;116S:S11-S18
pubmed: 31072689
J Clin Invest. 2020 Jan 2;130(1):214-230
pubmed: 31763997
Nat Commun. 2019 May 21;10(1):2243
pubmed: 31113973
J Immunol. 2019 Dec 1;203(11):2917-2927
pubmed: 31611259
JAMA Netw Open. 2018 Oct 5;1(6):e183779
pubmed: 30646264
Nat Immunol. 2010 Aug;11(8):701-8
pubmed: 20581831
Infect Immun. 2012 Sep;80(9):3256-67
pubmed: 22778103
J Exp Med. 1993 Jul 1;178(1):1-16
pubmed: 8391057
Scand J Immunol. 2014 Oct;80(4):271-5
pubmed: 24846411
J Immunol. 2015 Sep 1;195(5):1927-32
pubmed: 26297792
J Exp Med. 2013 Oct 21;210(11):2305-20
pubmed: 24101382
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
Tuberculosis (Edinb). 2018 Jan;108:124-126
pubmed: 29523312
Immunology. 2015 Jul;145(3):443-53
pubmed: 25752900
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282828
Am J Respir Crit Care Med. 2018 May 1;197(9):1198-1208
pubmed: 29624071
Front Immunol. 2020 Feb 14;11:199
pubmed: 32117314
J Exp Med. 1999 Jun 21;189(12):1907-21
pubmed: 10377186
Epidemics. 2016 Mar;14:54-61
pubmed: 26972514
Lancet Infect Dis. 2016 Feb;16(2):227-38
pubmed: 26867464
Sci Rep. 2020 May 25;10(1):8629
pubmed: 32451443
EMBO Mol Med. 2015 Dec 18;8(2):86-95
pubmed: 26682570
J Exp Med. 2014 Jul 28;211(8):1585-600
pubmed: 25049336
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Commun Biol. 2019 Jun 5;2:203
pubmed: 31231693
J Infect. 2016 Mar;72(3):338-52
pubmed: 26724769
Blood. 2012 Jan 12;119(2):422-33
pubmed: 22086415
Immunol Cell Biol. 2018 Jul;96(6):573-587
pubmed: 29656544
PLoS Biol. 2010 Jun 29;8(6):e1000407
pubmed: 20613858
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Nat Immunol. 2013 Jul;14(7):706-13
pubmed: 23727893
J Immunol. 2018 Nov 15;201(10):2862-2871
pubmed: 30397170
Tuberculosis (Edinb). 2015 May;95(3):267-74
pubmed: 25837440
Front Immunol. 2019 Feb 19;10:260
pubmed: 30838000
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Tubercle. 1948 Nov;29(11):245-51
pubmed: 18101320